Hypocupremia: A Possible Association with Late Cortical Cerebellar Atrophy by Mittal, Shivam Om & Machado, Duarte G.
Case Reports
Hypocupremia: A Possible Association with Late Cortical Cerebellar Atrophy
Shivam Om Mittal
1*
& Duarte G. Machado
2
1Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, USA, 2Department of Neurology, Yale University School of
Medicine, New Haven, CT, USA
Abstract
Background: We report a patient, diagnosed with late cortical cerebellar atrophy, who had persistent low serum copper levels.
Case report: A 48-year-old male developed progressive difficulty with balance, frequent falls, and dysarthric speech, which worsened over a short time span. He
had an extensive ataxia work-up, which was unremarkable except for persistent low serum copper levels despite adequate supplementation. Magnetic resonance
imaging of the brain showed marked cerebellar atrophy. The patient experienced progressive worsening of symptoms, which did not improve with either oral or
parenteral copper supplementation.
Discussion: To our knowledge, ours is the first case report of late cortical cerebellar atrophy in the setting of low serum copper levels. The current report should
trigger further research in mechanisms leading to copper deficiency and its possible role in cerebellar disease.
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Introduction
Late cortical cerebellar atrophy (LCCA) is a type of non-hereditary
spinocerebellar degeneration; the first autopsy case of LCCA was
reported by Archambault in 1918.1 Marie et al.2 established a
foundation for the concept for LCCA by investigating four patients in
1922. Since then, LCCA has been considered a disease in which patients
develop cerebellar cortical lesions mainly in the cerebellar vermis. In
1975, Mancall3 classified LCCA into six categories. However, some
patients with LCCA of unknown cause have also been reported. An
autopsy study in four patients in Japan showed that there are two types
of cerebellar cortex lesions in idiopathic LCCA: one is vermis dominant
and the other is cerebellar hemisphere dominant.4
The cerebellar cortex has the second highest concentration of
copper in the human brain (33.1 mg of Cu per g of dry tissue).5
Compromised copper transport in the human brain may manifest as
severe and well-characterized neurodegenerative disorders, including
Menkes disease and Wilson’s disease. In addition to these disorders,
disturbances in the distribution of brain copper levels are associated
with other neurodegenerative diseases, including Alzheimer’s disease,
amyotrophic lateral sclerosis (ALS), Parkinson’s disease, Huntington’s
disease, and prion diseases.6–8 Alterations in brain copper levels are
thought to further contribute to cell death in these disorders by
enchancing protein aggregation, oxidative stress, and mitochondrial
dysfunction, although the precise homeostatic control of copper in the
human brain has not been fully elucidated.7
Copper deficiency has typically been reported as a cause of
myelopathy.9 Yet it may also be linked with other neurological
problems. Relevant to the current case is that Oishi et al.10 reported
that copper levels in hair were lower in 10 patients with LCCA than in
controls, suggesting a possible link between LCCA and low copper. To
our knowledge, ours is the first reported case of a patient diagnosed
with LCCA whose primary abnormality on extensive workup was a
low serum copper level.
Case report
We report on a 48-year-old right-handed male who initially
presented with worsening gait and balance. He was in his usual state
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of health until 3 years ago, when he began to experience progressive
difficulty with balance. While walking, he would find himself swaying
from side to side such that he had difficulty walking in a straight line.
He had difficulty climbing stairs and had several falls. He felt clumsy
and also noted speech difficulties. No past medical or family history of
neurological disorders was reported. His father died at 72 years of age
from cancer. His mother was alive and healthy. He had five healthy
siblings and a healthy 15-year-old son. On examination, his mental
status and cranial nerve examination were normal, with no ocular
findings. Sensory examination was normal bilaterally, and reflexes
were grade 2 throughout. Motor examination revealed normal muscle
power without atrophy. He had dysarthric speech, dysdiadochokinesia,
mild to moderate finger-to-nose ataxia, mild heel-to-shin ataxia, and
marked midline ataxia. His gait was abnormal with a wide-based
stance and shortened strides. He was unable to tandem gait (Video
Segment 1 and Segment 2).
Magnetic resonance imaging (MRI) of the brain revealed cortical
cerebellar atrophy. There was no structural change or any white
matter changes in the cerebellar peduncle (Figure 1). Extensive
serological work-up for ataxias was initiated. He had normal thyroid
function tests and vitamin levels, including vitamins B1, B6, B12,
folate, and E. He tested negative for heavy metal toxins including
arsenic, cadmium, and lead. He had negative anti-gliadin antibody,
tissue transglutaminase antibodies, endomysial antibody, anti-GAD 65
antibody, and HIV serology. A complete genetic ataxia panel, which
included autosomal dominant ataxias caused by mutations in the genes
associated with SCA 1, 2, 3, 5, 6, 7, 8, 10, 12, 13, 14, 17, 28 and
DRPLA, and autosomal recessive ataxias caused by mutations in genes
associated with SIL1, TTPA, FRDA, POLG, APTX, and SETX was
negative. He had negative titers for anti-neuronal nuclear Ab Type 1,
2 and 3, anti-glial nuclear Ab Type 1, Purkinje cell cytoplasmic Ab
Types 1 and 2, amphiphysin antibody, CRMP-5, IgG, tissue
transglutaminase IgA. Iron studies (iron, TIBC, iron saturation, and
ferritin) and zinc (0.9 mg/dL; 0.66–1.10 mg/mL) were normal. Initial
serum studies were notable for a low ceruloplasmin of 12 mg/dL
(reference range: 22–58 mg/dL) and low serum copper level of
Video Segment 1. Neurological Examination at First Visit. Neurological examination demonstrates mild dysdiadochokinesia and moderately impaired tandem
gait.
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0.45 mg/mL (reference range: 0.75–1.45 mg/mL). Thus, the patient
was started on oral copper supplementation at 6 mg/day of elemental
copper orally for a week, 4 mg/day for the second week, and 2 mg/
day thereafter. Unfortunately, the patient showed no improvement,
with continued gradual decline in his gait imbalance, and his repeat
serum copper remained low even on supplementation. He was
subsequently admitted to the hospital on two separate occasions for
intravenous copper infusions of 2 mg of elemental copper for 5
consecutive days. Again, his copper levels remained low. At multiple
points over a 3-year period, he had low serum copper ranging from
0.33 to 0.45 mg/mL and low ceruloplasmin ranging from 12 to
15 mg/dL as noted in the Table 1.
A 24-hour urine copper concentration was also low at 7 mg/L (normal
15–60 mg/L). Genetic testing was negative for heteroallelic ceruloplas-
min gene mutations. There were no deletions or mutation/duplications
in either ATP7A or ATP7B genes, thus ruling out occipital horn
syndrome and Wilson’s disease respectively. Fluorodeoxyglucose
Positron Emission Tomography scan of the brain revealed asymmetric
hypo-metabolism in the right cerebellum compared to the left side. He also
had small bowel and liver biopsies for quantitative copper determination
and analysis by light and electron microscopy: no copper was seen by light
microscopy. An elevated copper level was seen in liver tissue (69 mg/g dry
weight, reference range: 10–35 mg /g dry weight). MRI of the abdomen,
including iron quantification sequences, was normal. A DatScan I-123
isoflupane showed no scintigraphic evidence for dopamine transporter
deficits. Repeat brain MRI 2 years later revealed interval progression of
the now marked cerebellar atrophy. The patient showed no improvement,
with a gradual decline in his gait imbalance such that he became
wheelchair bound. He was postulated to have LCCA associated with low
serum copper levels. In this case, there may be additional abnormal
copper uptake mechanisms that remain to be elucidated.
Discussion
LCCA is non-hereditary spinocerebellar degeneration with a
prevalence of 0.69 per 100,000.11 The most common features are
cerebellar signs such as lower-limb ataxia (96%) and upper-limb ataxia
Video Segment 2. Neurological Examination at Follow-up after 6 Months. The patient has worsening neurological features with severely impaired tandem
gait and severe difficulty in balancing on one foot such that he nearly falls.
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(93%), followed by hypotonia (40%); patients may also have hyper-
reflexia (30%). Very few patients present with parkinsonian symptoms
such as rigidity (in lower limbs), tremor and oculomotor abnormal-
ities.11–13
Our patient had persistent hypocupremia. The most common
causes of copper deficiency are a remote gastrointestinal surgery, such
as gastric bypass surgery, with resultant malabsorption of copper, or
zinc toxicity.14 This patient had an extensive work-up, which ruled out
genetic conditions, occipital horn syndrome, and Wilson’s disease.
This patient had a low ceruloplasmin level, but evaluation of
heteroallelic ceruloplasmin gene mutations was negative. The
significance of a low ceruloplasmin concentration in patients with a
variety of neurological syndromes is not clear but can lead to
diagnostic confusion.15 A liver biopsy showed increased copper
concentrations. Serum iron and zinc levels were normal. Thus, the
cause of copper deficiency in this patient remains unknown. Neither
oral nor parenteral supplementation of copper improved the patient’s
serum copper status. It is similarly interesting to note that parenteral
copper therapy in infants with Menkes’ kinky hair syndrome does not
lead to any clinical improvement and the cerebral and cerebellar
degeneration is considered to be irreversible.16
Oishi et al.10 compared hair copper levels in 10 LCCA patients to
several thousand controls, and showed a significantly lower copper level
in LCCA patients, raising the possibility that LCCA is associated with a
mild degree of copper deficiency. Medeiros et al.17 reported positive
correlations of tissue mineral analysis (TMA) copper levels in animals
based on three levels of dietary copper intake. TMA of hair has proven
to be a good method for assessing nutritional copper status.18,19
The cerebellar cortex is divided into molecular, Purkinje, granule,
and subcortical white matter. The molecular and granule cell layers
filter and temporally pattern information as it is transmitted to the
Purkinje layer, which is the sole recipient of this post-processed
information. The Purkinje layer sends inhibitory output to the deep
cerebellar nuclei and is an important modulating force on the deep
cerebellar nuclei.20 Purkinje cell lesions have been observed in autopsy
study of LCCA patients.4,21 Perinatal copper deficient rats demon-
strated irregularities in the Purkinje cell monolayer in the cerebellum
cortex compared to rats with adequate copper.22
To our knowledge, hypocupremia and its effects on the cerebellum
have not been studied in detail in humans. It is possible that
hypocupremia in our patient caused changes in the Purkinje cell layer
and cortical atrophy. This case is of further interest due to the severity
of this patient’s disease progression over a short time frame.
References
1. Archambault LS. Parenchymatous atrophy of the cerebellum: A contribu-
tion to the symptomatology of intrinsic cerebellar disease J Nerv Ment Dis 1918;48:
273–312, doi: http://dx.doi.org/10.1097/00005053-191810000-00001.
2. Marie P, Foix CH, Alajouanine TH. De I’atrophie cerebelleuse tardive a
predominance corticale. Rev Neurol(Paris) 1922;29:849–885, 1082–1111.
3. Mancall EL. Late (acquired) cortical cerebellar atrophy. In: Vinken PJ,
Bruyn GW, editors. Handbook of clinical neurology. Amsterdam, New York:
North Holland Press; 1975. p 477–508 (vol. 21).
4. Ota S, Tsuchiya K, Anno M, Niizato K, Akiyama H. Distribution of
cerebello-olivary degeneration in idiopathic late cortical cerebellar atrophy:
Clinicopathological study of four autopsy cases. Neuropathology 2008;28:43–50,
doi: http://dx.doi.org/10.1111/j.1440-1789.2007.00845.x.
5. Prohaska JR. Functions of trace elements in brain metabolism. Physiol Rev
1987;67:858–901.


















Figure 1. Magnetic Resonance Imaging of Brain Sagittal Section of T1
Sequence Showing Cerebellar Cortical Atrophy. No white matter changes
in the cerebellar peduncle
Mittal SO, Machado DG Hypocupremia: A Possible Association with LCCA
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services4
6. Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis
and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases
and amyotrophic lateral sclerosis). Chem Rev 2006 106:1995–2044.
7. Davies KM, Hare DJ, Cottam V, et al. Localization of copper and copper
transporters in the human brain. Metallomics 2013;5:43–51, doi: http://dx.doi.
org/10.1039/c2mt20151h.
8. Desai V, Kaler SG. Role of copper in human neurological disorders.
Am J Clin Nutr 2008;88:855S–8S.
9. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin
Proc 2006;81:1371–1384, doi: http://dx.doi.org/10.4065/81.10.1371.
10. Oishi M, Takasu T, Tateno M, Uchida H. Hair trace elements in
cerebellar degeneration: Low copper levels in late cortical cerebellar atrophy.
J Neurol 1990;237:163–165.
11. Hirayama K, Takayanagi T, Nakamura R, et al. Spinocerebellar
degenerations in Japan: A nationwide epidemiological and clinical study. Acta
Neurol Scand Suppl 1994;153:1–22, doi: http://dx.doi.org/10.1111/j.1600-0404.
1994.tb05401.x.
12. Richter RB. Late cortical cerebellar atrophy; a form of hereditary
cerebellar ataxia. Am J Hum Genet 1950;2:1–29.
13. Baloh RW, Yee RD, Honrubia V. Late cortical cerebellar atrophy.
Clinical and oculographic features. Brain 1986;109:159–180, doi: http://dx.doi.
org/10.1093/brain/109.1.159.
14. Kodama H, Fujisawa C, Bhadhprasit W. Inherited copper transport
disorders: Biochemical mechanisms, diagnosis, and treatment. Curr Drug Metab
2012;13:237–250, doi: http://dx.doi.org/10.2174/138920012799320455.
15. Walshe JM. Diagnostic significance of reduced serum ceruloplasmin
concentration in neurological disease. Mov Disord 2005;20:1658–1661, doi:
http://dx.doi.org/10.1002/mds.20628.
16. Nooijen JL, De Groot CJ, Van Den Hamer CJA, Monnens LAH,
Willemse J, Niermeijer MF. Trace element studies in three patients and a fetus
with Menkes’ disease. Effect of copper therapy. Pediatr Res 1981;15:284–289,
doi: http://dx.doi.org/10.1203/00006450-198103000-00017.
17. Medeiros DM, Liu CF, Wu BN. Copper and sodium concentration in rat
hair as related to dietary intake. Nutr Res 1984;3:923–928, doi: http://dx.doi.
org/10.1016/S0271-5317(83)80044-X.
18. Mao S, Zhang A, Huang S. Meta-analysis of Zn, Cu and Fe in the hair of
Chinese children with recurrent respiratory tract infection. Scand J Clin Lab Invest
Suppl 2014:1–7.
19. Suliburska J. A comparison of levels of select minerals in scalp hair
samples with estimated dietary intakes of these minerals in women of
reproductive age. Biol Trace Elem Res 2011;144:77–85, doi: http://dx.doi.org/
10.1007/s12011-011-9034-9.
20. Miall RC. Cerebellum: Anatomy and function. In: Ptaff DW, editor.
Neuroscience in the 21st Century. New York: Springer; 2013. p 1149–1167.
21. Iwabuchi K, Yagishita S. An autopsied case of idiopathic late cortical
cerebellar atrophy-comparison with other cortical cerebellar atrophy. Rinsho
Shinkeigaku 1990;30:1190–1196.
22. Lyons JA, Prohaska JR. Perinatal copper deficiency alters rat cerebellar
Purkinje cell size and distribution. Cerebellum 2010;9:136–144, doi: http://dx.
doi.org/10.1007/s12311-009-0136-2.
Hypocupremia: A Possible Association with LCCA Mittal SO, Machado DG
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org
The Center for Digital Research and Scholarship
Columbia University Libraries/Information Services5
